Real-world efficacy of nivolumab plus cabozantinib in metastatic renal cell carcinoma (mRCC) using the IMDC.Martín Zarbá, Daniel Yick Chin Heng, Parker Baumgarten et al.|Journal of Clinical Oncology|2026Cited by 0